Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-obesity Agents”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)WithdrawnNCT00735683
What this trial is testing

A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety

Who this might be right for
Obesity
Healios K.K.
Large-scale testing (Phase 3)WithdrawnNCT06619015
What this trial is testing

Tailoring Obesity Treatment Trial

Who this might be right for
ObesityAppetite RegulationPreDiabetes
Esbjerg Hospital - University Hospital of Southern Denmark
Testing effectiveness (Phase 2)Study completedNCT00402077
What this trial is testing

Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Who this might be right for
OverweightObesity
AstraZeneca 258
Large-scale testing (Phase 3)Study completedNCT00532779
What this trial is testing

The Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Who this might be right for
ObesityOverweight
Orexigen Therapeutics, Inc 1,742
Testing effectiveness (Phase 2)Study completedNCT00650806
What this trial is testing

The Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes

Who this might be right for
Obesity
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 376
Large-scale testing (Phase 3)Study completedNCT01028976
What this trial is testing

Obesity, Inflammation and Oxidative Stress

Who this might be right for
C-reactive ProteinInflammationObesity+1 more
University of California, Berkeley 512
Early research (Phase 1)Looking for participantsNCT06575738
What this trial is testing

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

Who this might be right for
ObesityAdolescent ObesityBody-Weight Trajectory+3 more
University of Colorado, Denver 40
Not applicableStudy completedNCT02241421
What this trial is testing

The Importance of the Gut Microbiota in Body Weight Control and Insulin Sensitivity

Who this might be right for
ObesityInsulin Resistance
Maastricht University Medical Center 57
Not applicableStudy completedNCT00108524
What this trial is testing

A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

Who this might be right for
Diabetes MellitusObesity
US Department of Veterans Affairs 146
Post-approval studies (Phase 4)Study completedNCT03779048
What this trial is testing

Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment

Who this might be right for
Obesity
University of Pennsylvania 147
Not applicableEnded earlyNCT01728116
What this trial is testing

Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese

Who this might be right for
Type 2 DiabetesObesity
Morphic Medical Inc. 325
Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT05215847
What this trial is testing

Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery

Who this might be right for
Bariatric SurgeryObesityWeight Gain
Aardvark Therapeutics, Inc. 12
Large-scale testing (Phase 3)Study completedNCT03336086
What this trial is testing

Effect of Weight Reduction on Immunity

Who this might be right for
LymphocytesWeight LossViral Diseases+2 more
Shiraz University of Medical Sciences 29
Not applicableActive Not RecruitingNCT05346575
What this trial is testing

TOTAL: A Multisite RCT

Who this might be right for
ObesityOverweight
VA Office of Research and Development 440
Not applicableStudy completedNCT05451927
What this trial is testing

Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of Lahore

Who this might be right for
Overweight and Obesity
Hafiza Aisha Sadiqa 72
Not applicableLooking for participantsNCT06752018
What this trial is testing

Inflammation's Impact on Heart Disease and Diabetes

Who this might be right for
InflammationObesity and Type 2 DiabetesObesity+2 more
University of Aarhus 250
Early research (Phase 1)Study completedNCT01979380
What this trial is testing

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Who this might be right for
Drug Toxicity
Kwang Dong Pharmaceutical co., ltd. 40
Not applicableNot Yet RecruitingNCT07387796
What this trial is testing

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

Who this might be right for
Drug DiscontinuationSubstance Use DisordersEating Behavior Changes+1 more
The University of Texas at Dallas 40
Testing effectiveness (Phase 2)Study completedNCT05121441
What this trial is testing

Study to Evaluate ARD-101 in Adults With Obesity

Who this might be right for
Obesity
Aardvark Therapeutics, Inc. 20
Load More Results